Sep 13, 2023 · 2 brokers have issued 12-month price targets for Qifu Technology's stock. Their QFIN share price forecasts range from $20.80 to $25.90. On average, they anticipate the company's stock price to reach $23.73 in the next year. This suggests a possible upside of 35.5% from the stock's current price. View analysts price targets for QFIN or view top ... Sep 14, 2023 · Anavex Life Sciences Corp. (NASDAQ: AVXL)’s stock price has gone rise by 0.91 in comparison to its previous close of 7.66, however, the company has experienced a 0.26% increase in its stock price over the last five trading days. GlobeNewsWire reported 2023-08-02 that NEW YORK, Aug. 02, 2023 (G Morphic Holding, Inc. (MORF) Surges 18.7%: Is This an Indication of Further Gains? Zacks - Fri Jan 13, 6:26AM CST . Morphic Holding, Inc. (MORF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...Morphic Holding Stock Chart and Share Price Forecast, Short-Term "MORF" Stock Prediction for Next Days and Weeks Walletinvestor.com Morphic Holding Inc (MORF) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 Aug 29, 2023 · Stifel Downgrades Morphic Holding to Hold From Buy, Adjusts Price Target to $61 From $69. Aug. 09. MT. Berenberg Initiates Morphic Holding With Buy Rating, $75 Price Target. Jul. 21. MT. BMO Capital Adjusts Price Target on Morphic Holding to $106 From $83, Maintains Outperform Rating. Apr. 26. MORF Earnings Date and Information. Morphic last released its earnings results on August 3rd, 2023. The reported ($0.92) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.90) by $0.02. Morphic has generated ($3.24) earnings per share over the last year ( ($3.24) diluted earnings per share).Sep 12, 2023 · Morphic Holding Stock (NASDAQ:MORF) Dividends: History, Yield and Dates Historical and Upcoming Morphic Holding Dividends. The dividend schedule below includes dividend amounts, payment dates and ... According to the issued ratings of 5 analysts in the last year, the consensus rating for Morphic stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for MORF. The average twelve-month price prediction for Morphic is $73.43 with a high price target of $106.00 and a low price target of $56.00.Sep 4, 2023 · On Friday, Morphic Holding Inc. [NASDAQ:MORF] saw its stock jump 1.51% to $55.91. On the same session, the stock had its day’s lowest price of $55.42, but rose to a high of $56.75. Over the last five days, the stock has gained 1.49%. Morphic Holding Inc. shares have risen nearly 109.01% since the year began. Morphic Therapeutic's Ulcerative Colitis Candidate Shows Clinically Meaningful Improvements Across Measures, Stock Soars Zacks 133d Morphic Holding, Inc. (MORF) Reports Q1 Loss, Lags Revenue EstimatesThe stock of Montrose Environmental Group Inc. (MEG) has gone down by -2.97% for the week, with a -13.22% drop in the past month and a -20.98% drop in the past quarter. The volatility ratio for the week is 5.40%, and the volatility levels for the past 30 days are 4.26% for MEG. The simple moving aveAnalyzing MORF Stock Performance. On Thursday, Morphic Holding Inc. [NASDAQ: MORF] rose 3.61% to $55.12. The stock’s lowest price that day was $53.22, but it reached a high of $56.20 in the same session. During the last five days, there has been a surge of approximately 2.89%.Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical ...Morphic Therapeutic's Ulcerative Colitis Candidate Shows Clinically Meaningful Improvements Across Measures, Stock Soars Zacks 133d Morphic Holding, Inc. (MORF) Reports Q1 Loss, Lags Revenue EstimatesMorphic Holding ( MORF ): It’s got a new drug. Miniso Group Holding ( MNSO ): Its U.S. expansion ought to go well. Celsius Holdings ( CELH ): Analysts love this company and stock. Source ... unmaskoxford wi Morphic Holding stock news, updates & related news. Find out why Morphic Holding's (MORF) news sentiment is 38.60% more negative in relation to stocks in the Healthcare sector.Aug 3, 2023 · Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -2.22% and 100%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -2.22% and 100%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? May 12, 2023 · Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering. May 3, 2023. WALTHAM, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of an underwritten ... Those same analysts give the stock an average rating of Strong Buy. That average rating earns MORF an Analyst Ranking of 72, which means it ranks higher than 72 of stocks, based on data compiled by InvestorsObserver .Sep 8, 2023 · The Morphic Holding, Inc. stock price gained 1.59% on the last trading day (Friday, 8th Sep 2023), rising from $53.57 to $54.42. During the last trading day the stock fluctuated 3.04% from a day low at $53.57 to a day high of $55.20. The price has been going up and down for this period, and there has been a 1.45% gain for the last 2 weeks. Sep 13, 2023 · A high-level overview of Morphic Holding, Inc. (MORF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The latest Morphic stock prices, stock quotes, news, and MORF history to help you invest and trade smarter. ... Morphic Stock Snapshot. 44.29 Bid. 100.00 Bid Size. 44.87 ...Phase 2b EMERALD-2 clinical trial of MORF-057 expected to begin mid-year 2022. WALTHAM, Mass., March 25, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), today announced the initiation of MORF-057-201, the EMERALD-1 study. EMERALD-1 is a phase 2a trial of MORF-057 in patients with moderate to severe ulcerative colitis.Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical ...Aug 25, 2023 · Morphic Holding stock was originally listed at a price of $18.00 in Jun 27, 2019. If you had invested in Morphic Holding stock at $18.00, your return over the last 4 years would have been 206.06%, for an annualized return of 32.27% (not including any dividends or dividend reinvestments). Those same analysts give the stock an average rating of Strong Buy. That average rating earns MORF an Analyst Ranking of 72, which means it ranks higher than 72 of stocks, based on data compiled by InvestorsObserver .The latest Morphic stock prices, stock quotes, news, and MORF history to help you invest and trade smarter. ... Morphic Stock Snapshot. 44.29 Bid. 100.00 Bid Size. 44.87 ... indigo credit card app Apr 26, 2022 · Analysts who follow Morphic Holding Inc (MORF) on average expect it to gain 121.97% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. Nov 5, 2020 · The price of the stock has decreased by 5.6% since. SVP Finance and CAO Robert E Farrell Jr sold 100 shares of MORF stock on 10/19/2020 at the average price of $28.05. The price of the stock has ... 5 equities research analysts have issued 12-month price objectives for Morphic's stock. Their MORF share price forecasts range from $56.00 to $106.00. On average, they expect the company's stock price to reach $73.43 in the next twelve months. This suggests a possible upside of 34.9% from the stock's current price.According to the issued ratings of 5 analysts in the last year, the consensus rating for Morphic stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for MORF. The average twelve-month price prediction for Morphic is $73.43 with a high price target of $106.00 and a low price target of $56.00.Morphic Holding Inc. analyst estimates, including MORF earnings per share estimates and analyst recommendations. Sep 15, 2023 · MORF’s Market Performance. Morphic Holding Inc. (MORF) has seen a 2.89% rise in stock performance for the week, with a 3.22% gain in the past month and a -7.86% plunge in the past quarter. The volatility ratio for the week is 3.60%, and the volatility levels for the past 30 days are at 3.92% for MORF.. The simple moving average for the past ... The stock price for . Morphic Holding (NASDAQ: MORF) is $55.73 last updated Today at August 29, 2023 at 4:42 PM UTC. Q Does Morphic Holding (MORF) pay a dividend?WALTHAM, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Marc Schegerin, MD, COO & CFO, will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, September 6 th at 8:00 AM ET.Morphic is developing small molecule inhibitors of the integrin α v β 8 through a combination immuno-oncology approach for the treatment of solid tumors as well as potential additional indications. α v β 8 is known to activate selective isoforms of TGF-β and Morphic has demonstrated that α v β 8 inhibition can potentiate immune checkpoint blockade and potentially drive responses in ...The latest Morphic stock prices, stock quotes, news, and MORF history to help you invest and trade smarter. ... Morphic Stock Snapshot. 44.29 Bid. 100.00 Bid Size. 44.87 ... dr mrs vandertramp Aug 3, 2023 · Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -2.22% and 100%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? Analyzing MORF Stock Performance. On Thursday, Morphic Holding Inc. [NASDAQ: MORF] plunged -0.69% to $53.57. The stock’s lowest price that day was $52.79, but it reached a high of $55.16 in the same session. During the last five days, there has been a drop of approximately -3.82%.Sep 12, 2023 · Analyst Forecast. According to 6 analysts, the average rating for MORF stock is "Buy." The 12-month stock price forecast is $76.33, which is an increase of 39.42% from the latest price. MORF-057: First-In-Class Oral Integrin Drug for IBD 7 Highly selective orally available small molecule inhibitor of α 4β 7, well validated mechanism for the treatment of IBD through approved monoclonal antibody vedolizumab MORF-057 Occluding α 4β 7 blocks intestinal homing of lymphocytes, which in turn reduces pathologic inflammation in IBDView the latest Morphic Holding Inc. (MORF) stock price, news, historical charts, analyst ratings and financial information from WSJ.Discover historical prices for MORF stock on Yahoo Finance. View daily, weekly or monthly format back to when Morphic Holding, Inc. stock was issued.Morphic Holding Inc. analyst estimates, including MORF earnings per share estimates and analyst recommendations. Real time Morphic (MORF) stock price quote, stock graph, news & analysis. Aug 29, 2023 · Stifel Downgrades Morphic Holding to Hold From Buy, Adjusts Price Target to $61 From $69. Aug. 09. MT. Berenberg Initiates Morphic Holding With Buy Rating, $75 Price Target. Jul. 21. MT. BMO Capital Adjusts Price Target on Morphic Holding to $106 From $83, Maintains Outperform Rating. Apr. 26. Read more to see why MORF stock is a Buy. Morphic revealed promising topline results from the primary cohort of the open-label Phase 2a EMERALD-1 trial. Read more to see why MORF stock is a Buy.Sep 6, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Morphic stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for MORF. The average twelve-month price prediction for Morphic is $73.43 with a high price target of $106.00 and a low price target of $56.00. Analyzing MORF Stock Performance. On Thursday, Morphic Holding Inc. [NASDAQ: MORF] rose 3.61% to $55.12. The stock’s lowest price that day was $53.22, but it reached a high of $56.20 in the same session. During the last five days, there has been a surge of approximately 2.89%.Who is on Morphic's Insider Roster? The list of insiders at Morphic includes Alexey Lugovskoy, Amir Nashat, Bruce Rogers, Fund V Gp L.P. Omega, Fund V L.P. Omega, Marc Schegerin, Peter Linde, Praveen P Tipirneni, Robert E Farrell Jr, Robert E. Farrell, Jr., Timothy A Springer, and William Devaul. Learn more on insiders at MORF.MORF Stock 12 Months Forecast. $81.75. (48.39% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Morphic Holding in the last 3 months. The average price target is $81.75 with a high forecast of $106.00 and a low forecast of $61.00. The average price target represents a 48.39% change from the last price of $55.09. Overview News Morphic Holding Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-3.23 Market Cap $2.68 B Shares Outstanding 47.92 M Public Float... MORF Stock 12 Months Forecast. $81.75. (48.39% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Morphic Holding in the last 3 months. The average price target is $81.75 with a high forecast of $106.00 and a low forecast of $61.00. The average price target represents a 48.39% change from the last price of $55.09. dc subway map MORF Stock 12 Months Forecast. $81.75. (48.39% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Morphic Holding in the last 3 months. The average price target is $81.75 with a high forecast of $106.00 and a low forecast of $61.00. The average price target represents a 48.39% change from the last price of $55.09. MORF Earnings Date and Information. Morphic last released its earnings results on August 3rd, 2023. The reported ($0.92) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.90) by $0.02. Morphic has generated ($3.24) earnings per share over the last year ( ($3.24) diluted earnings per share).Morphic Holding (MORF, $53.64) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 24, 2023. Tickeron - Stocks • 11 days ago. Morphic Holding (MORF, $54.54) entered Uptrend as Momentum indicator ascends above 0 level on Aug 23, 2023. Tickeron - Stocks • 11 days ago.Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical ... It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... santa fe public schools Morphic Holding, Inc. Common Stock (MORF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.1 day ago · As of right now, Morphic Holding Inc. [MORF] is trading at $55.12, up 3.61%. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The MORF shares have gain 2.89% over the last week, with a monthly amount glided 3.22%, and seem to be holding up Sep 8, 2023 · MORF’s short interest falls to 2.62 million shares. Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Morphic Holding Inc. shares valued at $205,187 were sold by Tipirneni Praveen P. on Aug 01. At $57.04 per share, Tipirneni Praveen P. sold 3,597 shares. Sep 13, 2023 · A high-level overview of Morphic Holding, Inc. (MORF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. View the latest Morphic Holding Inc. (MORF) stock price, news, historical charts, analyst ratings and financial information from WSJ.Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical ...Phase 2b EMERALD-2 clinical trial of MORF-057 expected to begin mid-year 2022. WALTHAM, Mass., March 25, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), today announced the initiation of MORF-057-201, the EMERALD-1 study. EMERALD-1 is a phase 2a trial of MORF-057 in patients with moderate to severe ulcerative colitis.1 day ago · As of right now, Morphic Holding Inc. [MORF] is trading at $55.12, up 3.61%. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The MORF shares have gain 2.89% over the last week, with a monthly amount glided 3.22%, and seem to be holding up japan ski resorts The latest Morphic stock prices, stock quotes, news, and MORF history to help you invest and trade smarter. ... Morphic Stock Snapshot. 44.29 Bid. 100.00 Bid Size. 44.87 ... Anavex Life Sciences Corp. (NASDAQ: AVXL)’s stock price has gone rise by 0.91 in comparison to its previous close of 7.66, however, the company has experienced a 0.26% increase in its stock price over the last five trading days. GlobeNewsWire reported 2023-08-02 that NEW YORK, Aug. 02, 2023 (GPrice Performance Review of MORF. On Friday, Morphic Holding Inc. [NASDAQ:MORF] saw its stock jump 1.51% to $55.91. On the same session, the stock had its day’s lowest price of $55.42, but rose to a high of $56.75. Over the last five days, the stock has gained 1.49%. Morphic Holding Inc. shares have risen nearly 109.01% since the year began.Apr 26, 2023 · The 99 rating InvestorsObserver gives to Morphic Holding Inc (MORF) stock puts it near the top of the Healthcare heritage high school frisco MORF Earnings Date and Information. Morphic last released its earnings results on August 3rd, 2023. The reported ($0.92) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.90) by $0.02. Morphic has generated ($3.24) earnings per share over the last year ( ($3.24) diluted earnings per share).Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical ...Apr 26, 2023 · The 99 rating InvestorsObserver gives to Morphic Holding Inc (MORF) stock puts it near the top of the Healthcare domain.com login Aug 28, 2020 · Analysts who follow Morphic Holding Inc (MORF) on average expect it to increase 17.65% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. Oct 15, 2020 · As of 2023 August 31, Thursday current price of MORF stock is 55.360$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). Morphic Holding stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. According to the issued ratings of 5 analysts in the last year, the consensus rating for Morphic stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for MORF. The average twelve-month price prediction for Morphic is $73.43 with a high price target of $106.00 and a low price target of $56.00.Corporate Profile. Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform. Morphic believes oral drugs targeting the integrin protein family can transform the treatment paradigm for patients suffering from serious chronic ...1 day ago · As of right now, Morphic Holding Inc. [MORF] is trading at $55.12, up 3.61%. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The MORF shares have gain 2.89% over the last week, with a monthly amount glided 3.22%, and seem to be holding up What this means: Morphic Holding Inc (MORF) gets an Overall Rank of 68, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Discover historical prices for MORF stock on Yahoo Finance. View daily, weekly or monthly format back to when Morphic Holding, Inc. stock was issued.Analyzing MORF Stock Performance. On Thursday, Morphic Holding Inc. [NASDAQ: MORF] plunged -0.69% to $53.57. The stock’s lowest price that day was $52.79, but it reached a high of $55.16 in the same session. During the last five days, there has been a drop of approximately -3.82%.Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Morphic Holding Inc have a median target of 70.00, with a high estimate of 106.00 and a low estimate of 60.00. The median ...Aug 23, 2023 · Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for MORF stock stock is $73.5, which predicts an increase of 32.79%. The lowest target is $44 and the highest is $106. On average, analysts rate MORF stock stock as a strong buy. Morphic Holding ( MORF ): It’s got a new drug. Miniso Group Holding ( MNSO ): Its U.S. expansion ought to go well. Celsius Holdings ( CELH ): Analysts love this company and stock. Source ...Morphic (MORF) (Delayed Data from NSDQ) $54.42 USD +0.85 (1.59%) Updated Sep 8, 2023 04:00 PM ET After-Market: $54.35 -0.07 (-0.13%) 7:58 PM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores:...Aug 29, 2023 · WALTHAM, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Marc Schegerin, MD, COO & CFO, will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, September 6 th at 8:00 AM ET. we become what we behold WALTHAM, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Marc Schegerin, MD, COO & CFO, will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, September 6 th at 8:00 AM ET.Read more to see why MORF stock is a Buy. Morphic revealed promising topline results from the primary cohort of the open-label Phase 2a EMERALD-1 trial. Read more to see why MORF stock is a Buy.Analyzing MORF Stock Performance. On Thursday, Morphic Holding Inc. [NASDAQ: MORF] rose 3.61% to $55.12. The stock’s lowest price that day was $53.22, but it reached a high of $56.20 in the same session. During the last five days, there has been a surge of approximately 2.89%.60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. % of Institutional Shareholders: The percent of ownership held by large financial institutions or organizations. The latest Morphic stock prices, stock quotes, news, and MORF history to help you invest and trade smarter. ... Morphic Stock Snapshot. 44.29 Bid. 100.00 Bid Size. 44.87 ...MORF Stock 12 Months Forecast. $81.75. (48.39% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Morphic Holding in the last 3 months. The average price target is $81.75 with a high forecast of $106.00 and a low forecast of $61.00. The average price target represents a 48.39% change from the last price of $55.09. Discover historical prices for MORF stock on Yahoo Finance. View daily, weekly or monthly format back to when Morphic Holding, Inc. stock was issued. May 26, 2023 · Morphic Holding stock news, updates & related news. Find out why Morphic Holding's (MORF) news sentiment is 38.60% more negative in relation to stocks in the Healthcare sector. saved edit Aug 23, 2023 · Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for MORF stock stock is $73.5, which predicts an increase of 32.79%. The lowest target is $44 and the highest is $106. On average, analysts rate MORF stock stock as a strong buy. MORF Stock 12 Months Forecast. $81.75. (48.39% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Morphic Holding in the last 3 months. The average price target is $81.75 with a high forecast of $106.00 and a low forecast of $61.00. The average price target represents a 48.39% change from the last price of $55.09.Apr 26, 2023 · The 99 rating InvestorsObserver gives to Morphic Holding Inc (MORF) stock puts it near the top of the Healthcare The Morphic Holding, Inc. stock price gained 1.59% on the last trading day (Friday, 8th Sep 2023), rising from $53.57 to $54.42. During the last trading day the stock fluctuated 3.04% from a day low at $53.57 to a day high of $55.20. The price has been going up and down for this period, and there has been a 1.45% gain for the last 2 weeks.Aug 9, 2023 · Morphic Therapeutic's Ulcerative Colitis Candidate Shows Clinically Meaningful Improvements Across Measures, Stock Soars Zacks 133d Morphic Holding, Inc. (MORF) Reports Q1 Loss, Lags Revenue Estimates According to 6 analysts, the average rating for MORF stock is "Buy." The 12-month stock price forecast is $76.33, which is an increase of 39.42% from the latest price.Morphic (MORF) (Delayed Data from NSDQ) $54.42 USD +0.85 (1.59%) Updated Sep 8, 2023 04:00 PM ET After-Market: $54.35 -0.07 (-0.13%) 7:58 PM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores:...Co. has also developed selective oral avß6-specific integrin inhibitors including MORF-720 and MORF-627. When considering the Morphic Holding Inc stock dividend history, we have taken known splits into account, such that the MORF dividend history is presented on a split-adjusted ("apples to apples") basis. Read more to see why MORF stock is a Buy. Morphic revealed promising topline results from the primary cohort of the open-label Phase 2a EMERALD-1 trial. Read more to see why MORF stock is a Buy.The Morphic Holding stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.Aug 25, 2023 · Morphic Holding stock was originally listed at a price of $18.00 in Jun 27, 2019. If you had invested in Morphic Holding stock at $18.00, your return over the last 4 years would have been 206.06%, for an annualized return of 32.27% (not including any dividends or dividend reinvestments). Morphic Holding, Inc. Common Stock (MORF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. imaginemath Apr 26, 2022 · Analysts who follow Morphic Holding Inc (MORF) on average expect it to gain 121.97% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. Those same analysts give the stock an average rating of Strong Buy. That average rating earns MORF an Analyst Ranking of 72, which means it ranks higher than 72 of stocks, based on data compiled by InvestorsObserver .1 day ago · As of right now, Morphic Holding Inc. [MORF] is trading at $55.12, up 3.61%. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The MORF shares have gain 2.89% over the last week, with a monthly amount glided 3.22%, and seem to be holding up Morphic Holding, Inc. (MORF) Surges 18.7%: Is This an Indication of Further Gains? Zacks - Fri Jan 13, 6:26AM CST . Morphic Holding, Inc. (MORF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near... dolar uol Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Morphic Holding Inc have a median target of 70.00, with a high estimate of 106.00 and a low estimate of 60.00. The median ...See Morphic Holding, Inc. (MORF) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Overview News Morphic Holding Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-3.23 Market Cap $2.68 B Shares Outstanding 47.92 M Public Float... Sep 15, 2023 · MORF’s Market Performance. Morphic Holding Inc. (MORF) has seen a 2.89% rise in stock performance for the week, with a 3.22% gain in the past month and a -7.86% plunge in the past quarter. The volatility ratio for the week is 3.60%, and the volatility levels for the past 30 days are at 3.92% for MORF.. The simple moving average for the past ... Morf-stock How did you originally get into stock? I had just gotten a new camera and started playing with Photoshop when I found DeviantArt and their stock section. After using a few stock images I thought it might be fun to post a few images I wasn't using at the time in hopes someone may find it useful in something they were worki Morphic Holding, Inc. Common Stock (MORF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Morphic Holding Inc have a median target of 70.00, with a high estimate of 106.00 and a low estimate of 60.00. The median ... msp 2 Sep 15, 2023 · MORF Earnings Date and Information. Morphic last released its earnings results on August 3rd, 2023. The reported ($0.92) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.90) by $0.02. Morphic has generated ($3.24) earnings per share over the last year ( ($3.24) diluted earnings per share). The average Morphic Holding stock price prediction forecasts a potential upside of 47.74% from the current MORF share price of $54.42. What is MORF's forecast return on assets (ROA) for 2023-2025? (NASDAQ: MORF) forecast ROA is -27.46%, which is lower than the forecast US Biotechnology industry average of 11.98%.Jul 20, 2023 · As of Thursday, July 20, Morphic Holding Inc’s MORF share price has surged by 4.11%, which has investors questioning if this is right time to sell. Premium Products Basic Membership Access to Journal, Shadow Stock portfolio & monthly updates for stock screens MORF’s Market Performance. Morphic Holding Inc. (MORF) has seen a 2.89% rise in stock performance for the week, with a 3.22% gain in the past month and a -7.86% plunge in the past quarter. The volatility ratio for the week is 3.60%, and the volatility levels for the past 30 days are at 3.92% for MORF.. The simple moving average for the past ...5 equities research analysts have issued 12-month price objectives for Morphic's stock. Their MORF share price forecasts range from $56.00 to $106.00. On average, they expect the company's stock price to reach $73.43 in the next twelve months. This suggests a possible upside of 34.9% from the stock's current price. myauto Sep 4, 2023 · On Friday, Morphic Holding Inc. [NASDAQ:MORF] saw its stock jump 1.51% to $55.91. On the same session, the stock had its day’s lowest price of $55.42, but rose to a high of $56.75. Over the last five days, the stock has gained 1.49%. Morphic Holding Inc. shares have risen nearly 109.01% since the year began. Morphic Holding, Inc. Common Stock (MORF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.The Morphic Holding, Inc. stock price gained 1.59% on the last trading day (Friday, 8th Sep 2023), rising from $53.57 to $54.42. During the last trading day the stock fluctuated 3.04% from a day low at $53.57 to a day high of $55.20. The price has been going up and down for this period, and there has been a 1.45% gain for the last 2 weeks.Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical ... cape hatteras motel Morf-stock How did you originally get into stock? I had just gotten a new camera and started playing with Photoshop when I found DeviantArt and their stock section. After using a few stock images I thought it might be fun to post a few images I wasn't using at the time in hopes someone may find it useful in something they were worki myjourney MORF Stock 12 Months Forecast. $81.75. (48.39% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Morphic Holding in the last 3 months. The average price target is $81.75 with a high forecast of $106.00 and a low forecast of $61.00. The average price target represents a 48.39% change from the last price of $55.09.Phase 2b EMERALD-2 clinical trial of MORF-057 expected to begin mid-year 2022. WALTHAM, Mass., March 25, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), today announced the initiation of MORF-057-201, the EMERALD-1 study. EMERALD-1 is a phase 2a trial of MORF-057 in patients with moderate to severe ulcerative colitis.Stifel Downgrades Morphic Holding to Hold From Buy, Adjusts Price Target to $61 From $69. Aug. 09. MT. Berenberg Initiates Morphic Holding With Buy Rating, $75 Price Target. Jul. 21. MT. BMO Capital Adjusts Price Target on Morphic Holding to $106 From $83, Maintains Outperform Rating. Apr. 26.Morf-stock How did you originally get into stock? I had just gotten a new camera and started playing with Photoshop when I found DeviantArt and their stock section. After using a few stock images I thought it might be fun to post a few images I wasn't using at the time in hopes someone may find it useful in something they were worki Aug 8, 2023 · Who is on Morphic's Insider Roster? The list of insiders at Morphic includes Alexey Lugovskoy, Amir Nashat, Bruce Rogers, Fund V Gp L.P. Omega, Fund V L.P. Omega, Marc Schegerin, Peter Linde, Praveen P Tipirneni, Robert E Farrell Jr, Robert E. Farrell, Jr., Timothy A Springer, and William Devaul. Learn more on insiders at MORF. Overview Stock Screener Earnings Calendar Sectors Nasdaq | MORF U.S.: Nasdaq Morphic Holding Inc. Watch list After Hours Last Updated: Jul 21, 2023 4:01 p.m. EDT Delayed quote $ 56.87 0.00...Morphic Holding, Inc. Common Stock (MORF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering. May 3, 2023. WALTHAM, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of an underwritten ...Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Morphic Holding Inc have a median target of 70.00, with a high estimate of 106.00 and a low estimate of 60.00. The median ... les fleurs du mal 1 day ago · As of right now, Morphic Holding Inc. [MORF] is trading at $55.12, up 3.61%. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The MORF shares have gain 2.89% over the last week, with a monthly amount glided 3.22%, and seem to be holding up Sep 13, 2023 · View SilverBow Resources SBOW investment & stock information. Get the latest SilverBow Resources SBOW detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Morphic Holding Stock Chart and Share Price Forecast, Short-Term "MORF" Stock Prediction for Next Days and Weeks Walletinvestor.com Morphic Holding Inc (MORF) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 Apr 26, 2022 · Analysts who follow Morphic Holding Inc (MORF) on average expect it to gain 121.97% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. amazon.com shopping online Morf-stock How did you originally get into stock? I had just gotten a new camera and started playing with Photoshop when I found DeviantArt and their stock section. After using a few stock images I thought it might be fun to post a few images I wasn't using at the time in hopes someone may find it useful in something they were workiJul 29, 2023 · Despite the fact that the share price increased 79.36% in the last 6 months and 18.96% was added to its value over the previous 3 months. MORF stock is trading at a margin of -2.70%, -4.35% and 36.24% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices. MORF’s Market Performance. Morphic Holding Inc. (MORF) has seen a 2.89% rise in stock performance for the week, with a 3.22% gain in the past month and a -7.86% plunge in the past quarter. The volatility ratio for the week is 3.60%, and the volatility levels for the past 30 days are at 3.92% for MORF.. The simple moving average for the past ...Apr 18, 2023 · We are initiating MORF stock with a speculative buy rating based on a) a clear catalyst: phase 2a UC data (EMERALD-1) expected in 2Q 23, b) de-risked mechanism of action (with Entyvio's approval ... receipt book Real time Morphic (MORF) stock price quote, stock graph, news & analysis.Aug 29, 2023 · Stifel Downgrades Morphic Holding to Hold From Buy, Adjusts Price Target to $61 From $69. Aug. 09. MT. Berenberg Initiates Morphic Holding With Buy Rating, $75 Price Target. Jul. 21. MT. BMO Capital Adjusts Price Target on Morphic Holding to $106 From $83, Maintains Outperform Rating. Apr. 26. Sep 8, 2023 · Morphic (MORF) (Delayed Data from NSDQ) $54.42 USD +0.85 (1.59%) Updated Sep 8, 2023 04:00 PM ET After-Market: $54.35 -0.07 (-0.13%) 7:58 PM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores:... Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Morphic Holding Inc have a median target of 70.00, with a high estimate of 106.00 and a low estimate of 60.00. The median ...Morf-stock How did you originally get into stock? I had just gotten a new camera and started playing with Photoshop when I found DeviantArt and their stock section. After using a few stock images I thought it might be fun to post a few images I wasn't using at the time in hopes someone may find it useful in something they were worki 8:33a Stock-index futures remain mostly higher after economic data 8:33a Lear raises 2023 sales outlook to $22.35 bln-$23.05 bln from $21.2 bln-$22.2 bln to be replacedSep 15, 2023 · MORF’s Market Performance. Morphic Holding Inc. (MORF) has seen a 2.89% rise in stock performance for the week, with a 3.22% gain in the past month and a -7.86% plunge in the past quarter. The volatility ratio for the week is 3.60%, and the volatility levels for the past 30 days are at 3.92% for MORF.. The simple moving average for the past ... anneliese michel Who is on Morphic's Insider Roster? The list of insiders at Morphic includes Alexey Lugovskoy, Amir Nashat, Bruce Rogers, Fund V Gp L.P. Omega, Fund V L.P. Omega, Marc Schegerin, Peter Linde, Praveen P Tipirneni, Robert E Farrell Jr, Robert E. Farrell, Jr., Timothy A Springer, and William Devaul. Learn more on insiders at MORF.Aug 2, 2023 · The 76 rating InvestorsObserver gives to Morphic Holding Inc stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 95 percent of stocks in the Biotechnology industry, MORF’s 76 overall rating means the stock scores better than 76 percent of all stocks. Read more to see why MORF stock is a Buy. Morphic revealed promising topline results from the primary cohort of the open-label Phase 2a EMERALD-1 trial. Read more to see why MORF stock is a Buy.The latest Morphic stock prices, stock quotes, news, and MORF history to help you invest and trade smarter. ... Morphic Stock Snapshot. 44.29 Bid. 100.00 Bid Size. 44.87 ... MORF-057 well tolerated in all dose cohorts. 2. MORF-057 achieved greater than 95% mean receptor occupancy of integrin at three highest dose levels; demonstrates ability to saturate receptor Morphic Reports Positive Interim Results from Single Ascending Dose Phase 1 Clinical Trial of MORF-057 1. MORF-057 well tolerated in all dose cohorts. 2. fanfic net Aug 29, 2023 · WALTHAM, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Marc Schegerin, MD, COO & CFO, will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, September 6 th at 8:00 AM ET. The 75 rating InvestorsObserver gives to Morphic Holding Inc ( MORF) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 90 percent of stocks in the Biotechnology industry, MORF’s 75 overall rating means the stock scores better than 75 percent of all stocks. MORF has an Overall Score of 75.Over the course of the year, Morphic lost $1.47 per share, down from $2.69 per share in the year prior. Its revenue also grew to $44.9 million, up from $17 million. Investors should note that this ...MORF-057 well tolerated in all dose cohorts. 2. MORF-057 achieved greater than 95% mean receptor occupancy of integrin at three highest dose levels; demonstrates ability to saturate receptor Morphic Reports Positive Interim Results from Single Ascending Dose Phase 1 Clinical Trial of MORF-057 1. MORF-057 well tolerated in all dose cohorts. 2.